Zobrazeno 1 - 10
of 221
pro vyhledávání: ''
Publikováno v:
Hormone and Metabolic Research. 53:402-407
Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are antidiabetic drugs with effects beyond antihyperglycemic action. The aim of the study was to examine whether a single dose of exenatide could be used as a stimulation test for the pituitary-ad
Autor:
Stefanie W. Benoit, Brandon Michael Henry, Giuseppe Lippi, Isaac Cheruiyot, Emmanuel J. Favaloro, Justin L. Benoit, Zoltán Prohászka
Publikováno v:
Seminars in Thrombosis and Hemostasis
Autor:
Dimitrios Giannis, Mark Goldin, Stuart L. Cohen, Alex C. Spyropoulos, Kevin Coppa, Mathew A. Barish, Saurav Chatterjee, Thomas McGinn, Jamie S. Hirsch, Eugenia Gianos, Nina Kohn, Martin Lesser
Publikováno v:
Thrombosis and Haemostasis
Thromb Haemost
Thromb Haemost
Background We aimed to identify the prevalence and predictors of venous thromboembolism (VTE) or mortality in hospitalized coronavirus disease 2019 (COVID-19) patients. Methods A retrospective cohort study of hospitalized adult patients admitted to a
Autor:
Patrick Haider, Joseph Pultar, Johann Wojta, Svitlana Demyanets, Patricia P. Wadowski, Simon Panzer, Beate Eichelberger, Stefan Stojkovic, Silvia Lee, Constantin Weikert, Christian Hengstenberg, Thomas Gremmel
Publikováno v:
Thrombosis and Haemostasis. 121:913-922
Background Monocyte–platelet aggregates (MPAs) are a sensitive marker of in vivo platelet activation in acute coronary syndrome (ACS) and associated with clinical outcomes. MicroRNAs (miRs) play an important role in the regulation of platelet activ
Publikováno v:
Drug Research. 71:157-165
The aim of this study is to investigate whether sitagliptin can be used as an initial drug for T2DM and to evaluate its effects on metabolic parameters in relation to its glycemic efficacies. The subjects received 25−50 mg/day sitagliptin monothera
Publikováno v:
Experimental and Clinical Endocrinology & Diabetes. 129:762-769
Background and Study Aims Thyroid-associated orbitopathy, the most common extrathyroidal manifestation of Graves’ disease, is an autoimmune inflammation of orbital soft tissue. We report the study assessing the effect of immunosuppressive treatment
Autor:
Mariangela Scavone, J. Rizzo, Gian Marco Podda, Marco Cattaneo, Sabrina Caberlon, Rita Paroni, Elena Bossi, Eti Alessandra Femia
Publikováno v:
Thrombosis and Haemostasis. 120:1442-1453
Essential thrombocythemia (ET) patients are treated with aspirin (acetylsalicylic acid [ASA]) to prevent thrombosis. Previous studies showed that serum thromboxane (Tx) B2 was high 24 hours after enteric-coated (EC)-ASA in ET patients, due to increas
Publikováno v:
Thrombosis and haemostasis, 120(6), 899-911. Schattauer GmbH
As a result of the successful completion of their respective phase III studies compared with vitamin K antagonists (VKAs), four direct oral anticoagulants (DOACs) have been approved for the treatment and secondary prevention of venous thromboembolism
Autor:
Laura Handgriff, Nina Nirschl, Leah T. Braun, Max Seidensticker, Roland Ladurner, Christian Adolf, Lisa Sturm, Martin Reincke, Daniel A. Heinrich, Martin Bidlingmaier, Jens Ricke
Publikováno v:
Hormone and Metabolic Research
Excess aldosterone is associated with the increased risk of cardio-/cerebrovascular events as well as metabolic comorbidities not only due to its hypertensive effect but also due to its proinflammatory action. Autonomous cortisol secretion (ACS) in t
Autor:
Bernhard, Benedikt, Stickel, Felix
Publikováno v:
Zeitschrift für Gastroenterologie. 58:451-455
Relapses after therapy with direct-acting antiviral agents (DAA) in chronic hepatitis C virus (HCV) infections are rare due to high efficacy of interferon-free therapy regimens. The presence of resistance-associated substitutions (RAS) in proteins ta